R Street Institute’s Wayne Brough talks about how the US patent system helps keep prescription drug prices high

Brand-name drug companies routinely abuse the U.S. patent system to amass junk patents, which they then use to block competitors from entering the market.

When that happens, drug prices skyrocket.

As Economist Wayne Brough of R Street Institute explains, “you’ll see [drug] prices go up 200, 500% because [brand-name drug companies] have no fear of competition coming into the marketplace.”